| 17 Hydroxyprogesterone (17-OHP) |
BG1001 |
Serum (YCT) |
Daily |
2 days |
Biochemical Genetics |
| Achondroplasia Mutation Analysis (FGFR3) |
MG3001 |
5ml Blood in K2 EDTA Tube (LCT) |
Daily |
15 days |
Molecular Genetics |
| ACTN3 Sports Gene Genotyping |
MG3002 |
5 ml Blood in K2 EDTA Tube (LCT)/ Buccal Swab |
Tue |
15 days |
Molecular Genetics |
| Acute Intermittent Porphyria |
SP5002 |
5ml Blood in K2/K3 EDTA Tube (LCT) |
Daily |
5 weeks |
Advanced Genomics |
| ADRB2 Gentoyping for Beta-2 Agonist Responsiveness |
MG3101 |
5ml Blood in K2/K3 EDTA Tube (LCT) |
Fri |
8 days |
Molecular Genetics |
| AKT1 Mutation Analysis (E17K) |
MG3004 |
5 ml Blood or 3 ml Bone marrow in K2 EDTA Tube (LCT) |
Tue |
7 days |
Molecular Genetics |
| Alkaptonuria Qualitative, Urine |
BG1003 |
Morning Urine (SCT) |
Daily |
5 days |
Biochemical Genetics |
| Alpha 1 Antitrypsin Genotype Analysis (Z, X , M Mutations) |
MG3003 |
5ml Blood in K2 EDTA Tube (LCT) |
Fri |
15 days |
Molecular Genetics |
| Alpha Thalassemia PCR |
MG3005 |
5ml Blood in K2 EDTA Tube (LCT) |
Sat |
15 days |
Molecular Genetics |
| AneuFiSH-1 Marker Chromosome 21 Aneuploidy Screen (AF) |
CG2001 |
10 ml Amniotic Fluid in Sterile Culture Tube |
Daily |
7 days |
Cytogenetics |
| AneuFiSH-1 Marker Chromosome 21 Aneuploidy Screen (CB) |
CG2002 |
5 ml Venous Blood Sod. Heparin Tube (GCT) |
Daily |
7 days |
Cytogenetics |
| AneuFiSH-1 Marker Chromosome 21 Aneuploidy Screen (VB) |
CG2003 |
5 ml Venous Blood Sod. Heparin Tube (GCT) |
Daily |
7 days |
Cytogenetics |
| AneuFiSH-1 Markers Chromosome 13 Aneuploidy Screen (CB) |
CG2004 |
5 ml Venous Blood Sod. Heparin Tube (GCT) |
Daily |
7 days |
Cytogenetics |
| AneuFiSH-1 Markers Chromosome 13 Aneuploidy Screen (AF) |
CG2005 |
10 ml Amniotic Fluid in Sterile Culture Tube |
Daily |
7 days |
Cytogenetics |
| AneuFiSH-1 Markers Chromosome 13 Aneuploidy Screen (VB) |
CG2006 |
2 ml Fetal, Cord Blood Sod. Heparin Tube (GCT) |
Daily |
7 days |
Cytogenetics |
| AneuFiSH-1 Markers Chromosome 18 Aneuploidy Screen (CB) |
CG2007 |
5 ml Venous Blood Sod. Heparin Tube (GCT) |
Daily |
7 days |
Cytogenetics |
| AneuFiSH-1 Markers Chromosome 18 Aneuploidy Screen (AF) |
CG2008 |
10 ml Amniotic Fluid in Sterile Culture Tube |
Daily |
7 days |
Cytogenetics |
| AneuFiSH-1 Markers Chromosome 18 Aneuploidy Screen (VB) |
CG2009 |
2 ml Fetal, Cord Blood Sod. Heparin Tube (GCT) |
Daily |
7 days |
Cytogenetics |
| AneuFiSH-3 Markers Chromosome 13, 18, 21 Aneuploidy Screen (AF) |
CG2010 |
10 ml Amniotic Fluid in Sterile Culture Tube |
Daily |
7 days |
Cytogenetics |
| AneuFiSH-3 Markers Chromosome 13, 18, 21 Aneuploidy Screen (CB) |
CG2011 |
2 ml Fetal, Cord Blood Sod. Heparin Tube (GCT) |
Daily |
7 days |
Cytogenetics |
| AneuFiSH-3 Markers Chromosome 13, 18, 21 Aneuploidy Screen (POC) |
CG2013 |
POC in Sterile Container having Saline+5 drops Gentamycin |
Daily |
7 days |
Cytogenetics |
| AneuFiSH-3 Markers Chromosome 13, 18, 21 Aneuploidy Screen (VB) |
CG2012 |
2 ml Fetal, Cord Blood Sod. Heparin Tube (GCT) |
Daily |
7 days |
Cytogenetics |
| AneuFiSH-5 Markers Chromosomal 13, 18, 21, X, Y Aneuploidy Screen (AF) |
CG2014 |
10 ml Amniotic Fluid in Sterile Culture Tube |
Daily |
7 days |
Cytogenetics |
| AneuFiSH-5 Markers Chromosomal 13, 18, 21, X, Y Aneuploidy Screen (CB) |
CG2015 |
2 ml Fetal, Cord Blood Sod. Heparin Tube (GCT) |
Daily |
7 days |
Cytogenetics |
| AneuFiSH-5 Markers Chromosomal 13, 18, 21, X, Y Aneuploidy Screen (POC) |
CG2031 |
POC in Sterile Container having Saline+5 drops Gentamycin |
Daily |
7 days |
Cytogenetics |
| AneuFiSH-5 Markers Chromosomal 13, 18, 21, X, Y Aneuploidy Screen (VB) |
CG2063 |
5 ml Venous Blood Sod. Heparin Tube (GCT) |
Daily |
7 days |
Cytogenetics |
| Aneuploidy PCR Detection (13,15,16,18,21,22,X&Y) amniotic fluid |
MG3102 |
5 ml Amniotic Fluid in Sterile Container |
Mon, Thu |
5 days |
Molecular Genetics |
| Aneuploidy PCR Detection (13,15,16,18,21,22,X&Y) blood |
MG3103 |
5ml Blood in K2/K3 EDTA Tube (LCT) |
Mon, Thu |
5 days |
Molecular Genetics |
| Aneuploidy PCR Detection (13,15,16,18,21,22,X&Y) POC |
MG3104 |
Product of Conception (POC) in a sterile container with Normal Saline & Gentamycine. |
Mon, Thu |
5 days |
Molecular Genetics |
| Aneuploidy PCR Detection (13,15,16,18,21,22,X&Y) SEMEN |
MG3105 |
2 ml Semen in Sterile Container |
Mon, Thu |
5 days |
Molecular Genetics |
| Angelman Syndrome Methylation PCR |
MG3106 |
5ml Blood or 3 ml Bone Marrow in K2/K3 EDTA Tube (LCT) |
Fri |
15 days |
Molecular Genetics |
| Angiotensin Converting Enzyme (ACE) I/D Polymorphism (Insertion/Deletion) |
MG3006 |
5 ml Blood in K2/K3 EDTA Tube (LCT)/ Buccal Swab |
Mon |
7 days |
Molecular Genetics |
| Apolipoprotein B (APOB) Mutation Analysis |
MG3007 |
5ml Blood in K2/K3 EDTA Tube (LCT) |
Mon |
7 days |
Molecular Genetics |
| ATN1 Trinucleotide Repeat Analysis (DRPLA-Dentatorubral-pallidoluysian atrophy) |
MG3008 |
5 ml Blood in K2/K3 EDTA Tube (LCT) |
Daily |
15 days |
Molecular Genetics |
| Beta Thalassemia Molecular Analysis (Beta globin (HBB) gene sequencing) |
MG3009 |
5 ml Blood in K2/K3 EDTA Tube (LCT) |
Daily |
10 days |
Molecular Genetics |
| Beta-thalassemia 5 Mutation Analysis |
MG3010 |
5 ml Blood in K2/K3 EDTA Tube (LCT) |
Daily |
10 days |
Molecular Genetics |
| BRAF Target Exon Analysis (Exon 11 & 15) |
MG3011 |
ST: FFPE or Tumor Tissue or FNA; HC: 5 ml Blood or 3 ml Bone marrow |
Daily |
7 days |
Molecular Genetics |
| BRAF V600E Mutation Analysis |
MG3012 |
ST: FFPE or Tumor Tissue or FNA; HC: 5 ml Blood or 3 ml Bone marrow |
Daily |
7 days |
Molecular Genetics |
| Calreticulin (CALR) Mutation Analysis |
MG3013 |
4 ml Blood or 3 ml Bone marrow in K2/K3 EDTA Tube (LCT) |
Daily |
8 days |
Molecular Genetics |
| CEBPA Mutation Analysis |
MG3014 |
5 ml Blood or 3 ml Bone marrow in EDTA Vacut. (PCT) |
Mon |
10 days |
Molecular Genetics |
| Chromosomal Analysis - Karyotyping (CF) |
CG2016 |
10-15 ml of Cystic Fluid in Sterile Culture Tube (SCT) |
Daily |
21 days |
Cytogenetics |
| Chromosomal Analysis - Karyotyping (AF) |
CG2017 |
20 mL Amniotic Fluid in Sterile Culture Tube (SCT) |
Daily |
15 days |
Cytogenetics |
| Chromosomal Analysis - Karyotyping (BM) |
CG2018 |
2 ml Bone Marrow in Sod. Heparin Tube (GCT) |
Daily |
21 days |
Cytogenetics |
| Chromosomal Analysis - Karyotyping (CB) |
CG2019 |
2mL Fetal or Cord Blood Sod.Heparin Tube (GCT) |
Daily |
15 days |
Cytogenetics |
| Chromosomal Analysis - Karyotyping (Hematological Cancers) |
CG2020 |
5-10 mL blood in Sod.Heparin Tube (GCT) |
Daily |
15 days |
Cytogenetics |
| Chromosomal Analysis - Karyotyping (VB) |
CG2021 |
5 mL Venous blood in Sod. Heparin Tube (GCT) |
Daily |
15 days |
Cytogenetics |
| Chromosomal Analysis - Karyotyping, Couples (VB) |
CG2022 |
5 mL Venous blood in Sod. Heparin Tube (GCT) |
Daily |
15 days |
Cytogenetics |
| Chromosomal Analysis HR Karyotyping (High Resolution Banding) |
CG2023 |
5 mL Blood Sod.Heparin Tube (GCT) |
Daily |
21 days |
Cytogenetics |
| Chromosomal Analysis, Karyotyping with reflex FISH (AF) |
CG2028 |
20 mL Amniotic Fluid in Sterile Culture Tube (SCT) |
Daily |
15 days |
Cytogenetics |
| Chromosomal Analysis, Karyotyping with reflex FISH (POC) |
CG2024 |
Products of Conception (POC) in Sterile Specimen Container (SSC) having Saline+5 drops gentamycin |
Daily |
21 days |
Cytogenetics |
| Chromosomal Breakage Analysis |
CG2025 |
5 mL Blood Sod. Heparin Tube (GCT) |
Daily |
21 days |
Cytogenetics |
| cKIT Mutation Analysis (D816V) |
MG3015 |
5 ml Blood or 3 ml Bone marrow in K2/K3 EDTA Tube (LCT) |
Tue |
8 days |
Molecular Genetics |
| Combi Chromosomal Analysis Karyotype & FISH Aneuploidy (Chr 13, 18, 21, X, Y) (AF) |
CG2026 |
20 mL Amniotic Fluid in 2 Sterile Culture TubeS (SCT) |
Daily |
FISH-7 days & KT 15 days |
Cytogenetics |
| Combi Chromosomal Analysis Karyotype & FISH Aneuploidy (Chr 13, 18, 21, X, Y) (VB) |
CG2027 |
5 ml Blood Sod. Heparin Tube (GCT) |
Daily |
FISH-7 days & KT 21 days |
Cytogenetics |
| Combi Chromosomal Analysis Karyotype & FISH Aneuploidy (Chr 13, 18, 21, X, Y) (CB) |
CG2029 |
2 ml Fetal or Cord Blood Sod. Heparin Tube (GCT) |
Daily |
FISH-7 days & KT 15 days |
Cytogenetics |
| CSF3R Mutation Analysis |
MG3129 |
5 ml Blood or 3 ml Bone marrow in K2/K3 EDTA Tube (LCT), Tumor Positive Tissue or FFPE Block [Formalin fix (10 percent neutral buffered formalin) and paraffin embed tissue] |
Daily |
7 days |
Molecular Genetics |
| CTNNB1 Mutation Analysis |
MG3128 |
Tumor Positive Tissue or FFPE Block [Formalin fix (10 percent neutral buffered formalin) and paraffin embed tissue] |
Daily |
7 days |
Molecular Genetics |
| CYP 2C19 Genotype Analysis (Clopidogrel Sensitivity Test) |
MG3019 |
5 ml Blood in K2/K3 EDTA Tube (LCT)/ Buccal Swab |
Daily |
7 days |
Molecular Genetics |
| CYP3A4*22 Genotype Analysis for Statins (Lipid Lowering Drugs) |
MG3016 |
5 ml Blood in K2/K3 EDTA Tube (LCT) |
Fri |
12 days |
Molecular Genetics |
| Cystic Fibrosis - CFTR Single Mutation Test (DeltaF508) |
MG3018 |
5 ml Blood in K2/K3 EDTA Tube (LCT) |
Daily |
7 days |
Molecular Genetics |
| Cystic Fibrosis 5 Common Mutation Test (CFTR-DeltaF508, R117H, 5T, G542X, G551D) |
MG3017 |
5 ml Blood in K2/K3 EDTA Tube (LCT) |
Daily |
7 days |
Molecular Genetics |
| DMD Mutation Screening 24 Exons (For Symptomatic Male Samples) |
MG3020 |
5 ml Blood in K2/K3 EDTA Tube (LCT) |
Tue, Fri |
15 days |
Molecular Genetics |
| DPD Gene Mutation for 5-Fluorouracil Toxicity Test (DPYD IVS14+1G>A) |
MG3021 |
5 ml Blood K2/K3 EDTA Tube (LCT) |
Daily |
7 days |
Molecular Genetics |
| EGFR Target Exons Sequencing (Exon 18, 19, 20, & 21) |
MG3022 |
Tumor Tissue or FFPE Block or FNA |
Daily |
5 days |
Molecular Genetics |
| Estrogen Receptor 1 (ESR1) Mutation Analysis (Exon 7 & 8) |
MG3107 |
Tumor Tissue or FFPE Block or FNA |
Fri |
7 days |
Molecular Genetics |
| Factor V Leiden Mutation Analysis (FVL-R506Q) |
MG3024 |
5 ml Blood in K2/K3 EDTA Tube (LCT) |
Daily |
7 days |
Molecular Genetics |
| FIP1L1-PDGFR-A Gene Rearrangement PCR |
MG3096 |
5 ml Blood or 3 ml Bone marrow in K2/K3 EDTA Tube (LCT), Tumor Positive Tissue or FFPE Block [Formalin fix (10 percent neutral buffered formalin) and paraffin embed tissue] |
Sat |
15 days |
Molecular Genetics |
| FiSH - Sex Mismatch X, Y Chromosome (Post BMT) |
CG2030 |
2 ml Bone Marrow Sod. Heparin Tube (GCT) |
Daily |
7 days |
Cytogenetics |
| FiSH SAT - Sperm Aneuploidy Test (Chr 13, 18, 21, X & Y) |
CG2032 |
1 ml Semen in Sterile Container (STC) |
Daily |
7 days |
Cytogenetics |
| FISH SRY Gene Deletion (Yp11.3) |
CG2033 |
5 ml Venous Blood or 2 ml Fetal, Cord Blood Sod. Heparin Tube (GCT) |
Daily |
9 days |
Cytogenetics |
| FLT3 Mutation Analysis (ITD & D835Y) |
MG3023 |
5 ml Blood or 3 ml Bone marrow in K2/K3 EDTA Tube (LCT) |
Wed,Sat |
5 days |
Molecular Genetics |
| Fragile X Repeat Expansion Analysis |
MG3026 |
5 ml Blood in K2/K3 EDTA Tube (LCT) |
Tue, Fri |
3 weeks |
Molecular Genetics |
| Friedreich's Ataxia Repeat Expansion Analysis |
MG3025 |
5 ml Blood in K2/K3 EDTA Tube (LCT) |
daily |
15 days |
Molecular Genetics |
| FSHR Mutation Analysis (S680 allele) |
MG3027 |
5 ml Blood in K2/K3 EDTA Tube (LCT) |
Daily |
7 days |
Molecular Genetics |
| G6PD deficiency Three Mutation Panel (G6PD Mediterranean (C563T), Kerala-Kalyan (G949A) & Orissa (C131G) |
MG3031 |
5 ml Blood in K2/K3 EDTA Tube (LCT) |
Daily |
7 days |
Molecular Genetics |
| Glycoprotein IIIa Mutation Analysis |
MG3030 |
5 ml Blood in K2/K3 EDTA Tube (LCT) |
Daily |
7 days |
Molecular Genetics |
| GNAS Mutation Analysis (Codon 201 & 227) Exon 8 & 9 |
MG3029 |
FFPE OR Fresh tumor tissue |
Daily |
7 days |
Molecular Genetics |
| HADHA Mutation Analysis |
MG3033 |
5ml Blood in K2/K3 EDTA Tube (LCT) |
Daily |
7 days |
Molecular Genetics |
| Haptoglobin Genotype Analysis |
MG3032 |
6 ml Blood in K2/K3 EDTA Tube (LCT) |
Daily |
10 days |
Molecular Genetics |
| HBB Beta Globin Full Gene Sequence Analysis |
MG3034 |
5 ml Blood in K2/K3 EDTA Tube (LCT) |
Daily |
10 days |
Molecular Genetics |
| Hemoglobin D Mutation (Iran / Punjab) |
MG3035 |
5 ml Blood in K2/K3 EDTA Tube (LCT) |
Mon, Wed |
10 days |
Molecular Genetics |
| Hemoglobin E Mutation Analysis Blood |
MG3036 |
5 ml Blood in K2/K3 EDTA Tube (LCT) |
Mon, Wed |
10 days |
Molecular Genetics |
| Hereditary Hemochromatosis (HFE) Three Mutation Analysis |
MG3037 |
5 ml Blood in K2/K3 EDTA Tube (LCT) |
Daily |
10 days |
Molecular Genetics |
| HLA Genotyping For Narcolepsy |
MG3038 |
5ml Blood or 3 ml Bone Marrow in K2/K3 EDTA Tube (LCT) |
Daily |
10 days |
Molecular Genetics |
| HLA-B1502 Genotyping Test (Carbamazepine Hypersensitivity) |
MG3039 |
5ml Blood in K2/K3 EDTA Tube (LCT) |
Daily |
4 days |
Molecular Genetics |
| HLA-B27 Genotyping Analysis (Ankylosing Spondylitis) |
MG3043 |
5ml Blood in K2/K3 EDTA Tube (LCT) |
Mon, Fri |
7 days |
Molecular Genetics |
| HLA-B5701 Genotype Test (Abacavir Hypersensitivity) |
MG3042 |
5ml Blood in K2/K3 EDTA Tube (LCT) |
Wed,Sat |
10 days |
Molecular Genetics |
| HLA-B5801 Genotyping Test (Allopurinol Hypersensitivity) |
MG3040 |
5ml Blood or 3 ml Bone Marrow in K2/K3 EDTA Tube (LCT) |
Daily |
10 days |
Molecular Genetics |
| HmLH-1 & HMSH-2 (Repair Genes) Molecular Analysis |
MG3028 |
5ml Blood in K2/K3 EDTA Tube (LCT) |
Daily |
10 days |
Molecular Genetics |
| HRAS Mutation Analysis |
MG3044 |
5 ml Blood in K2/K3 EDTA Tube (LCT) |
Daily |
7 days |
Molecular Genetics |
| Huntington Disease Mutation Analysis |
MG3045 |
5 ml Blood in K2/K3 EDTA Tube (LCT) |
Mon |
15 days |
Molecular Genetics |
| IDH1 & IDH2 Target Mutation Analysis |
MG3047 |
FFPE Block or Tumor Tissue/ 5ml Blood or 3 ml Bone Marrow in K2/K3 EDTA Tube (LCT) |
Daily |
10 days |
Molecular Genetics |
| Imatinib Resistance Mutation Analysis (IRMA) |
MG3048 |
5 ml Blood or 3 ml Bone marrow in K2/K3 EDTA Tube (LCT) |
Fri |
7 days |
Molecular Genetics |
| Inosine Triphosphatase & Interleukin 28B (ITPA) Genotype Analysis |
MG3046 |
5ml Blood in K2/K3 EDTA Tube (LCT) |
Daily |
7 days |
Molecular Genetics |
| Inv 16 - t(16-16) (p13q22) Gene Rearrangement Qualitative PCR |
MG3095 |
3 mL Whole Blood / 2 mL Bone Marrow in EDTA Tube (LCT) [Clinical history is mandatory] |
Wed, Sat |
7 days |
Molecular Genetics |
| JAK2 Exon 12 Sequence Analysis |
MG3049 |
5ml Blood or 3 ml Bone Marrow in K2/K3 EDTA Tube (LCT) |
Daily |
7 days |
Molecular Genetics |
| JAK2 Target Exons Sequence Analysis |
MG3050 |
5ml Blood or 3 ml Bone Marrow in K2/K3 EDTA Tube (LCT) |
Daily |
10 days |
Molecular Genetics |
| JAK2 V617F Mutation Analysis |
MG3100 |
5ml Blood or 3 ml Bone Marrow in K2/K3 EDTA Tube (LCT) |
Daily |
7 days |
Molecular Genetics |
| KIT Exon 17 Mutation Analysis |
MG3126 |
5 ml Blood or 3 ml Bone marrow in K2/K3 EDTA Tube (LCT), Tumor Positive Tissue or FFPE Block [Formalin fix (10 percent neutral buffered formalin) and paraffin embed tissue] |
Daily |
7 days |
Molecular Genetics |
| KRAS One Mutation Analysis |
MG3053 |
Tumor Positive Tissue or FFPE Block [Formalin fix (10 percent neutral buffered formalin) and paraffin embed tissue] |
Daily |
7 days |
Molecular Genetics |
